Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Digestive system drugs >  Antacid and Mucosal protective Drugs >  OLSALAZINE

OLSALAZINE

Basic information Safety Supplier Related

OLSALAZINE Basic information

Product Name:
OLSALAZINE
Synonyms:
  • Ph-CJ-91B
  • 4,4'-Dihydroxyazobenzene-3,3'-dicarboxylic acid
  • 5,5'-Azodisalicylic acid
  • 3,3'-(1,2-diazenediyl)bis[6-hydroxy-Benzoic acid
  • OLSALAZINE
  • 3,3’-azobis(6-hydroxy-benzoicaci
  • 3,3’-azobis(6-hydroxybenzoicacid)
  • 5,5’-azobis(salicylicacid)
CAS:
15722-48-2
MF:
C14H10N2O6
MW:
302.24
EINECS:
605-089-5
Mol File:
15722-48-2.mol
More
Less

OLSALAZINE Chemical Properties

Melting point:
>300 °C(Solv: acetic acid (64-19-7); water (7732-18-5))
Boiling point:
443.29°C (rough estimate)
Density 
1.3578 (rough estimate)
refractive index 
1.6500 (estimate)
pka
2.40±0.10(Predicted)
Water Solubility 
11.49ug/L(25 ºC)
CAS DataBase Reference
15722-48-2(CAS DataBase Reference)
More
Less

OLSALAZINE Usage And Synthesis

Uses

Anti-inflammatory (gastrointestinal).

Definition

ChEBI: An azobenzene that consists of two molecules of 4-aminosalicylic acid joined by an azo linkage. A prodrug for mesalazine, an anti-inflammatory drug, it is used (as the disodium salt) in the treatment of inflammatory bowel disease.

Indications

Olsalazine is approved for maintenance of remission of ulcerative colitis, but a commonly reported side effect is a paradoxical increase in diarrhea. The U. S. Food and Drug Administration (FDA) has approved balsalazide disodium (Colazal) as a treatment of mild to moderately active ulcerative colitis.

brand name

Dipentum (UCB).

Mechanism of action

Olsalazine is approved for maintenance of remission of ulcerative colitis, but a commonly reported side effect is a paradoxical increase in diarrhea. The U. S. Food and Drug Administration (FDA) has approved balsalazide disodium (Colazal) as a treatment of mild to moderately active ulcerative colitis.

Veterinary Drugs and Treatments

Olsalazine is used for treatment of dogs with chronic colitis that either cannot tolerate the adverse effects associated with sulfasalazine or the response to sulfasalazine has been ineffective.

OLSALAZINE Preparation Products And Raw materials

Raw materials

OLSALAZINESupplier

Shanghai Boyle Chemical Co., Ltd.
Tel
021-50182298 021-50180596
Email
sales@boylechem.com
Shanghai YuLue Chemical Co., Ltd.
Tel
021-60345187 13671753212
Email
lzz841106@aliyun.com
Chizhou Kailong Import and Export Trade Co., Ltd.
Tel
Email
xg01_gj@163.com
Alfa Chemistry
Tel
1-516-6625404
Email
support@alfa-chemistry.com
Jilin Chinese Academy of Sciences - Yanshen Technology Co., Ltd
Tel
0431-80514535 19917294565
Email
et@chemextension.com